{"date":"2026-09-03","count":14,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6875-2026-09-03-2304-19onne2","company_id":"6875","company":"國邑*","market":"上櫃","industry":"生技醫療","date":"2026-09-03","time":"23:04:13","subject":"本公司吸入新藥L606用於治療間質性肺病相關肺高壓(PH-ILD)之全球第三期樞紐臨床試驗(Re-Spire)設計將發表於2026年歐洲呼吸學會年會(ERS 2026)","clause":"第53款","fact_date":"2026-09-08","cite_as":"公開資訊觀測站重大訊息：國邑*（6875），2026-09-03 23:04，「本公司吸入新藥L606用於治療間質性肺病相關肺高壓(PH-ILD)之全球第三期樞紐臨床試驗(Re-Spire)設計將發表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-09-03-1959-1ap8fql","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-09-03","time":"19:59:58","subject":"公告本公司註銷收回之限制員工權利新股辦理減資變更登記完成","clause":"第36款","fact_date":"2026-09-03","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-09-03 19:59，「公告本公司註銷收回之限制員工權利新股辦理減資變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6734-2026-09-03-1857-vw02y1","company_id":"6734","company":"安盛生","market":"興櫃","industry":"生技醫療","date":"2026-09-03","time":"18:57:46","subject":"公告本公司經主管機關核准撤銷115年現金增資案","clause":"第44款","fact_date":"2026-09-03","cite_as":"公開資訊觀測站重大訊息：安盛生（6734），2026-09-03 18:57，「公告本公司經主管機關核准撤銷115年現金增資案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7827-2026-09-03-1814-z7nhjh","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2026-09-03","time":"18:14:34","subject":"代子公司FBD Biologics Limited公告，公司向美國FDA提出HCB303新藥臨床試驗(IND)申請","clause":"第10款","fact_date":"2026-09-03","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2026-09-03 18:14，「代子公司FBD Biologics Limited公告，公司向美國FDA提出HCB303新藥臨床試驗(IND)申請」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6892-2026-09-03-1752-10qn6yl","company_id":"6892","company":"台寶生醫","market":"興櫃","industry":"生技醫療","date":"2026-09-03","time":"17:52:14","subject":"公告本公司更換股務代理機構案經集保公司准予備查","clause":"第44款","fact_date":"2026-09-03","cite_as":"公開資訊觀測站重大訊息：台寶生醫（6892），2026-09-03 17:52，「公告本公司更換股務代理機構案經集保公司准予備查」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7827-2026-09-03-1716-1kwd8dt","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2026-09-03","time":"17:16:07","subject":"本公司受邀參加統一證券2026Q3全球展望秋季投資論壇","clause":"第12款","fact_date":"2026-09-04","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2026-09-03 17:16，「本公司受邀參加統一證券2026Q3全球展望秋季投資論壇」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6467-2026-09-03-1647-12zd1jo","company_id":"6467","company":"泰合","market":"興櫃","industry":"生技醫療","date":"2026-09-03","time":"16:47:22","subject":"本公司將於115年9月16日召開上市前業績發表會","clause":"第30款","fact_date":"2026-09-16","cite_as":"公開資訊觀測站重大訊息：泰合（6467），2026-09-03 16:47，「本公司將於115年9月16日召開上市前業績發表會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7754-2026-09-03-1548-5ux89o","company_id":"7754","company":"安基生技","market":"興櫃","industry":"生技醫療","date":"2026-09-03","time":"15:48:59","subject":"公告本公司開發中新藥AJ201向美國食品藥物管理局(US FDA)提出甘迺迪氏症第三期臨床試驗申請","clause":"第44款","fact_date":"2026-09-03","cite_as":"公開資訊觀測站重大訊息：安基生技（7754），2026-09-03 15:48，「公告本公司開發中新藥AJ201向美國食品藥物管理局(US FDA)提出甘迺迪氏症第三期臨床試驗申請」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6564-2026-09-03-1518-bjwvzb","company_id":"6564","company":"安特羅","market":"興櫃","industry":"生技醫療","date":"2026-09-03","time":"15:18:12","subject":"公告本公司發行現金增資乙案擬申請展延募集時間三個月","clause":"第44款","fact_date":"2026-09-03","cite_as":"公開資訊觀測站重大訊息：安特羅（6564），2026-09-03 15:18，「公告本公司發行現金增資乙案擬申請展延募集時間三個月」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4161-2026-09-03-1349-i6olxw","company_id":"4161","company":"聿新科","market":"上櫃","industry":"生技醫療","date":"2026-09-03","time":"13:49:08","subject":"公告本公司註銷限制員工權利新股註銷減資變更登記完成","clause":"第36款","fact_date":"2026-09-03","cite_as":"公開資訊觀測站重大訊息：聿新科（4161），2026-09-03 13:49，「公告本公司註銷限制員工權利新股註銷減資變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2026-09-03-1143-1o192kk","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2026-09-03","time":"11:43:16","subject":"本公司董事長訂定現金減資換股基準日暨換發股票作業計畫等相關事宜","clause":"第11款","fact_date":"2026-09-03","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2026-09-03 11:43，「本公司董事長訂定現金減資換股基準日暨換發股票作業計畫等相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2026-09-03-1141-1toz467","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2026-09-03","time":"11:41:57","subject":"公告本公司辦理現金減資變更登記完成","clause":"第36款","fact_date":"2026-09-03","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2026-09-03 11:41，「公告本公司辦理現金減資變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2026-09-03-1141-1ppi0i3","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2026-09-03","time":"11:41:32","subject":"本公司收回已發行之限制員工權利新股辦理註銷減資變更登記完成","clause":"第36款","fact_date":"2026-09-03","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2026-09-03 11:41，「本公司收回已發行之限制員工權利新股辦理註銷減資變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2026-09-03-1141-1ffxuo3","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2026-09-03","time":"11:41:06","subject":"公告本公司辦理庫藏股註銷減資變更登記完成","clause":"第36款","fact_date":"2026-09-03","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2026-09-03 11:41，「公告本公司辦理庫藏股註銷減資變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}